163 related articles for article (PubMed ID: 17210137)
1. Risperidone and cognitive function in children with disruptive behavior disorders.
Pandina GJ; Bilder R; Harvey PD; Keefe RS; Aman MG; Gharabawi G
Biol Psychiatry; 2007 Aug; 62(3):226-34. PubMed ID: 17210137
[TBL] [Abstract][Full Text] [Related]
2. Risperidone in children with disruptive behavior disorders and subaverage intelligence: a 1-year, open-label study of 504 patients.
Croonenberghs J; Fegert JM; Findling RL; De Smedt G; Van Dongen S;
J Am Acad Child Adolesc Psychiatry; 2005 Jan; 44(1):64-72. PubMed ID: 15608545
[TBL] [Abstract][Full Text] [Related]
3. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
4. Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.
Snyder R; Turgay A; Aman M; Binder C; Fisman S; Carroll A;
J Am Acad Child Adolesc Psychiatry; 2002 Sep; 41(9):1026-36. PubMed ID: 12218423
[TBL] [Abstract][Full Text] [Related]
5. Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQ.
Findling RL; Aman MG; Eerdekens M; Derivan A; Lyons B;
Am J Psychiatry; 2004 Apr; 161(4):677-84. PubMed ID: 15056514
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence.
Aman MG; De Smedt G; Derivan A; Lyons B; Findling RL;
Am J Psychiatry; 2002 Aug; 159(8):1337-46. PubMed ID: 12153826
[TBL] [Abstract][Full Text] [Related]
7. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
[TBL] [Abstract][Full Text] [Related]
8. Cognitive function with long-term risperidone in children and adolescents with disruptive behavior disorder.
Pandina GJ; Zhu Y; Cornblatt B
J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):749-56. PubMed ID: 20035593
[TBL] [Abstract][Full Text] [Related]
9. Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs.
Turgay A; Binder C; Snyder R; Fisman S
Pediatrics; 2002 Sep; 110(3):e34. PubMed ID: 12205284
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy of disruptive behavior and item changes on a standardized rating scale: pooled analysis of risperidone effects in children with subaverage IQ.
Aman M; Buitelaar J; Smedt GD; Wapenaar R; Binder C
J Child Adolesc Psychopharmacol; 2005 Apr; 15(2):220-32. PubMed ID: 15910206
[TBL] [Abstract][Full Text] [Related]
11. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
Aman MG; Binder C; Turgay A
J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
[TBL] [Abstract][Full Text] [Related]
12. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
[TBL] [Abstract][Full Text] [Related]
13. Long-term use of risperidone in children with disruptive behavior disorders and subaverage intelligence: efficacy, safety, and tolerability.
Reyes M; Croonenberghs J; Augustyns I; Eerdekens M
J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):260-72. PubMed ID: 16768634
[TBL] [Abstract][Full Text] [Related]
14. Risperidone for the treatment of affective symptoms in children with disruptive behavior disorder: a post hoc analysis of data from a 6-week, multicenter, randomized, double-blind, parallel-arm study.
Biederman J; Mick E; Faraone SV; Wozniak J; Spencer T; Pandina G
Clin Ther; 2006 May; 28(5):794-800. PubMed ID: 16861101
[TBL] [Abstract][Full Text] [Related]
15. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia.
Kim SW; Shin IS; Kim JM; Lee SH; Lee YH; Yang SJ; Yoon JS
Hum Psychopharmacol; 2009 Oct; 24(7):565-73. PubMed ID: 19790174
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia.
Rémillard S; Pourcher E; Cohen H
J Int Neuropsychol Soc; 2008 Jan; 14(1):110-8. PubMed ID: 18078537
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders.
Reyes M; Buitelaar J; Toren P; Augustyns I; Eerdekens M
Am J Psychiatry; 2006 Mar; 163(3):402-10. PubMed ID: 16513860
[TBL] [Abstract][Full Text] [Related]
18. Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers.
Allain H; Tessier C; Bentué-Ferrer D; Tarral A; Le Breton S; Gandon M; Bouhours P
Psychopharmacology (Berl); 2003 Feb; 165(4):419-29. PubMed ID: 12459926
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study.
Troost PW; Lahuis BE; Steenhuis MP; Ketelaars CE; Buitelaar JK; van Engeland H; Scahill L; Minderaa RB; Hoekstra PJ
J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1137-44. PubMed ID: 16239862
[TBL] [Abstract][Full Text] [Related]
20. Treating disruptive behavior disorders with risperidone: a 1-year, open-label safety study in children and adolescents.
Haas M; Karcher K; Pandina GJ
J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):337-45. PubMed ID: 18759643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
